Leverkusen, Germany — Bayer MaterialScience will acquire the remaining shares in the 50:50 systems house joint venture Baulé SAS from Eximium SAS and other shareholders, effective 31 March.
The joint venture was established in 2008 by Bayer MaterialScience and Michel Baulé SA, which later was renamed Eximium SAS. Baulé SAS is a global leader in the development, formulation and processing of polyurethane cast elastomers, BMS said in a 30 March news release.
Baulé is based in Romans, France, and has subsidiaries in the US, the UK, France and China. The transaction affects 139 employees, all of whom will be retained. Financial details have not been disclosed.
“The complete acquisition of Baulé SAS enables us to expand our potential for cast elastomers and also provides us with even greater access to this attractive market,” said Dr Wilhelm Lamberts, president of Baulé and current managing director of a BMS systems house in Oldenburg, Germany.